E@ECIPE
📣 @HelloFrankLavin writes @Forbes about the future of @wto. ➡️https://t.co/cs0X0NvIouRT Maria Volanen @MariaVolanen: @ECIPE @MatBauerEcon The consequences of OECD Pillar I and II proposals on small open economies might be quite unde… https://t.co/nqngkSPX5m.@ECIPE is now live on YouTube! ⚠️Watch the Webinar: Unintended and Undesired Consequences – The Impacts of OECD Pi… https://t.co/yx8HkEQN2pRT Daniel Bunn @danieldbunn: After #taxtwitter is done hearing @PSaintAmans' discussion with @iiea, tune in to hear from me and a few others on… https://t.co/6rCCCEoUEJ📆 Today at 3pm ➡️ Unintended and Undesired Consequences – The Impacts of @OECD Pillar I and II Proposals on Small O… https://t.co/lrIIMVmu2D
  • FOLLOW ECIPE
x
Browse

ECIPE Seminar: Trade and Patents – Taking Stock of an Export Waiver in Supplementary Patent Certificates

June 26 2018
Venue: ECIPE Office, Avenue des Arts 40, 6th floor, 1040 Brussels
Speakers: Christofer Fjellner, Doris Schernhammer, Maarten Meulenbelt, Matthias Bauer
Time: 14:15

Please join us for a seminar on trade and patents.

The value added created by Europe’s trade is far higher in IP-intensive sectors than elsewhere. Yet the same sectors also tend to be neglected when key priorities of trade and commercial policy are established. Furthermore, for many IP intensive sectors, the effective exclusivity granted by patents have gradually been eroded, and now they are at risk of being more eroded still. An idea drafted by the European Commission suggest that a new export waiver should be introduced in the system of Supplementary Patent Certificates, a policy intended to restore patent terms for products that have required long market approval processes.

Would an export waiver materially improve Europe’s exports – or do they risk lower high value added output?

Would they come with dynamic effects that could include higher prices in Europe?

Register for this event

Programme

Keynote address by Christofer Fjellner, Member of the European Parliament and its International Trade Committee

Panel:

Doris Schernhammer, Associate Director, Corporate Affairs Europe, Eli Lilly & Company

Maarten Meulenbelt, Partner, Sidley

Dr. Matthias Bauer, Senior Economist at ECIPE

Location